Diabetes News – Newsletter for July 14, 2010
Wednesday, July 14, 2010
Disruption in body clock genes could lead to diabetes
LONDON – A new animal study has shown that disruption of two genes that control circadian rhythms can lead to diabetes.
Circadian rhythms are cyclical patterns in biological activities, such as sleeping, eating, body temperature and hormone production.
“These results indicate that disruption of the daily clock may contribute to diabetes by impairing the pancreas’ ability to …. Original source : Disruption in body clock genes could lead to diabetes.
Experimental anti-obesity drug cuts body weight sans side effects
WASHINGTON – In a study on rodents, researchers have found that a second-generation experimental anti-obesity and diabetes drug could reduce body weight while avoiding the risk of psychiatric side effects linked with its predecessor rimonabant.
The first generation of anti-obesity drugs that targeted the cannabinoid receptor CB1 – such as rimonabant – showed great promise as …. Source : Experimental anti-obesity drug cuts body weight sans side effects.
Discovery offers new approach for diabetes therapy
WASHINGTON – Scientists have ‘cured’ laboratory mice of mild, diet-induced diabetes by stimulating the production of a particular enzyme.
According to researchers, the findings could offer a new approach to diabetes therapy, especially if a drug could be identified that would do the same thing, which in this case was accomplished with genetic manipulation.
Increased levels of …. Source : Gaea News Network.